Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.24M
2: EX-4.1 Instrument Defining the Rights of Security Holders HTML 38K
3: EX-10.29 Material Contract HTML 54K
4: EX-10.30 Material Contract HTML 46K
5: EX-10.33 Material Contract HTML 55K
6: EX-10.34 Material Contract HTML 55K
7: EX-10.35 Material Contract HTML 53K
8: EX-10.36 Material Contract HTML 961K
9: EX-10.37 Material Contract HTML 49K
10: EX-10.38 Material Contract HTML 370K
11: EX-10.39 Material Contract HTML 148K
12: EX-21.1 Subsidiaries List HTML 29K
13: EX-23.1 Consent of Experts or Counsel HTML 30K
18: EX-33 Report of Compliance with Servicing Criteria HTML 179K
14: EX-31.1 Certification -- §302 - SOA'02 HTML 37K
15: EX-31.2 Certification -- §302 - SOA'02 HTML 37K
16: EX-32.1 Certification -- §906 - SOA'02 HTML 32K
17: EX-32.2 Certification -- §906 - SOA'02 HTML 32K
25: R1 Cover Page HTML 87K
26: R2 Consolidated Balance Sheets HTML 118K
27: R3 Consolidated Balance Sheets (Parenthetical) HTML 51K
28: R4 Consolidated Statements of Operations HTML 91K
29: R5 Consolidated Statements of Stockholders' Equity HTML 95K
30: R6 Consolidated Statements of Cash Flows HTML 137K
31: R7 Nature of Business HTML 36K
32: R8 Liquidity and Capital Resources HTML 40K
33: R9 Significant Accounting Policies HTML 175K
34: R10 Stability Biologics, LLC HTML 68K
35: R11 Inventory HTML 42K
36: R12 Property and Equipment HTML 57K
37: R13 Leases HTML 60K
38: R14 Goodwill and Intangible Assets HTML 89K
39: R15 Accrued Expenses HTML 45K
40: R16 Long Term Debt HTML 70K
41: R17 Net (Loss) Income Per Share HTML 59K
42: R18 Equity HTML 108K
43: R19 Income Taxes HTML 169K
44: R20 Supplemental Disclosure of Cash Flow and Non-Cash HTML 46K
Investing and Financing Activities
45: R21 401(k) Plan HTML 34K
46: R22 Commitments and Contingencies HTML 111K
47: R23 Revenue Data by Customer Type HTML 48K
48: R24 Related Party Transactions HTML 36K
49: R25 Restructuring HTML 41K
50: R26 Quarterly Financial Data (Unaudited) HTML 84K
51: R27 Subsequent Events HTML 51K
52: R28 Schedule II - Valuation and Qualifying Accounts HTML 71K
53: R29 Significant Accounting Policies (Policies) HTML 239K
54: R30 Significant Accounting Policies (Tables) HTML 47K
55: R31 Stability Biologics, LLC (Tables) HTML 67K
56: R32 Inventory (Tables) HTML 44K
57: R33 Property and Equipment (Tables) HTML 59K
58: R34 Leases (Tables) HTML 59K
59: R35 Goodwill and Intangible Assets (Tables) HTML 133K
60: R36 Accrued Expenses (Tables) HTML 44K
61: R37 Long Term Debt (Tables) HTML 55K
62: R38 Net (Loss) Income Per Share (Tables) HTML 70K
63: R39 Equity (Tables) HTML 96K
64: R40 Income Taxes (Tables) HTML 164K
65: R41 Supplemental Disclosure of Cash Flow and Non-Cash HTML 45K
Investing and Financing Activities (Tables)
66: R42 Commitments and Contingencies (Tables) HTML 38K
67: R43 Revenue Data by Customer Type (Tables) HTML 46K
68: R44 Restructuring (Tables) HTML 38K
69: R45 Quarterly Financial Data (Unaudited) (Tables) HTML 84K
70: R46 Nature of Business (Details) HTML 32K
71: R47 Liquidity and Capital Resources (Details) HTML 40K
72: R48 Significant Accounting Policies (Details) HTML 109K
73: R49 Significant Accounting Policies - Assessment of HTML 60K
Revenue under ASC 606 (Details)
74: R50 Stability Biologics, LLC - Narrative (Details) HTML 81K
75: R51 Stability Biologics, LLC - Summary of Assets HTML 103K
Transferred and Consideration Received (Details)
76: R52 Inventory (Details) HTML 44K
77: R53 Property and Equipment - Property and Equipment HTML 48K
(Details)
78: R54 Property and Equipment - Depreciation (Details) HTML 39K
79: R55 Leases (Details) HTML 39K
80: R56 Leases - Supplemental Balance Sheet Information HTML 45K
(Details)
81: R57 Leases - Maturities of Operating Lease Liabilities HTML 51K
(Details)
82: R58 Leases - Future Minimum Operating Lease Payments HTML 49K
(Details)
83: R59 Goodwill and Intangible Assets - Intangible Assets HTML 61K
Activity Summary (Details)
84: R60 Goodwill and Intangible Assets - Narrative HTML 41K
(Details)
85: R61 Goodwill and Intangible Assets - Expected Future HTML 46K
Amortization of Intangible Assets (Details)
86: R62 Goodwill and Intangible Assets - Changes in HTML 35K
Carrying Amount of Goodwill (Details)
87: R63 Accrued Expenses (Details) HTML 49K
88: R64 Long Term Debt (Details) HTML 46K
89: R65 Long Term Debt - Term Loan (Details) HTML 58K
90: R66 Long Term Debt - Term Loan Balances (Details) HTML 50K
91: R67 Long Term Debt - Term Loan Interest Expense HTML 45K
(Details)
92: R68 Long Term Debt - Term Loan Maturity (Details) HTML 50K
93: R69 Net (Loss) Income Per Share - Computation of Basic HTML 58K
and Dilutive Net Loss per Share (Details)
94: R70 Net (Loss) Income Per Share - Summary of HTML 38K
Antidilutive Securities (Details)
95: R71 Equity - Narrative (Details) HTML 114K
96: R72 Equity - Activity of Stock Options (Details) HTML 77K
97: R73 Equity - 2019 Stock Option Modification (Details) HTML 46K
98: R74 Equity - Summary of Restricted Stock Awards HTML 55K
(Details)
99: R75 Equity - Recognized Stock-Based Compensation HTML 44K
(Details)
100: R76 Income Taxes - Deferred Tax Assets and Liabilities HTML 83K
(Details)
101: R77 Income Taxes - Narrative (Details) HTML 55K
102: R78 Income Taxes - Reconciliation of the Federal HTML 87K
Statutory Income Tax (Details)
103: R79 Income Taxes - Schedule of current and deferred HTML 58K
income tax expense (Benefit) (Details)
104: R80 Income Taxes - Reconciliation of unrecognized tax HTML 43K
benefits (Details)
105: R81 Supplemental Disclosure of Cash Flow and Non-Cash HTML 45K
Investing and Financing Activities (Details)
106: R82 401(k) Plan (Details) HTML 43K
107: R83 Commitments and Contingencies - Narrative HTML 96K
(Details)
108: R84 Commitments and Contingencies - Estimated Annual HTML 42K
Lease, Royalty, and Employment Agreement Expenses
(Details)
109: R85 Revenue Data by Customer Type (Details) HTML 47K
110: R86 Related Party Transactions (Details) HTML 43K
111: R87 Restructuring - Narrative (Details) HTML 37K
112: R88 Restructuring - Restructuring Reserve Liability HTML 39K
(Details)
113: R89 Quarterly Financial Data (Unaudited) (Details) HTML 58K
114: R90 Subsequent Events (Details) HTML 144K
115: R91 Schedule II - Valuation and Qualifying Accounts HTML 42K
(Details)
117: XML IDEA XML File -- Filing Summary XML 199K
24: XML XBRL Instance -- a2019annual10-k_htm XML 2.68M
116: EXCEL IDEA Workbook of Financial Reports XLSX 153K
20: EX-101.CAL XBRL Calculations -- mdxg-20191231_cal XML 358K
21: EX-101.DEF XBRL Definitions -- mdxg-20191231_def XML 705K
22: EX-101.LAB XBRL Labels -- mdxg-20191231_lab XML 2.21M
23: EX-101.PRE XBRL Presentations -- mdxg-20191231_pre XML 1.27M
19: EX-101.SCH XBRL Schema -- mdxg-20191231 XSD 204K
118: JSON XBRL Instance as JSON Data -- MetaLinks 478± 697K
119: ZIP XBRL Zipped Folder -- 0001376339-20-000045-xbrl Zip 913K
‘EX-23.1’ — Consent of Experts or Counsel
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
